Study assessing antibody response and safety recipients who unexpectedly received undiluted prime dose of BNT162b2 COVID-19 vaccine in Taiwan
Latest Information Update: 24 Jan 2023
At a glance
- Drugs Tozinameran (Primary)
- Indications COVID 2019 infections
- Focus Adverse reactions; Pharmacodynamics
Most Recent Events
- 24 Jan 2023 New trial record
- 01 Jan 2023 Results published in the Journal of the Formosan Medical Association